Skip to content
Politically.com Search all
Menu

2025 · 1st Quarter (Jan 1 - Mar 31)

ASSOCIATION FOR MOLECULAR PATHOLOGY

Filed by IPOLICY SOLUTIONS.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
1st Quarter - Report
Posted
Apr 11, 2025
Income
$70,500.00
Expenses
Not reported
Filing UUID
b09bda40-0329-4d40-a6b2-93e650e4bcf4
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

MED · Medical/Disease Research/Clinical Labs

No bill #: legislation to clarify CLIA FDA Final Rule: Laboratory Developed Tests S.J.Res.82 - A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Food and Drug Administration relating to "Medical Devices; Laboratory Developed Tests" HR 1463: Freedom for Laboratory Innovation and Testing Act

Literal federal measure citations: S.J.Res.82, HR 1463

CPT · Copyright/Patent/Trademark

No bill #: Patent Eligibility Restoration Act

BUD · Budget/Appropriations

No bill number: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026

HCR · Health Issues

HR 2471: Right Drug Dose Now Act

Literal federal measure citations: HR 2471

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.